On December 16, 2013, iTunes announced the availability of M*Modal Fluency Flex, V.2.0 for authorized customers of M*Modal Fluency For Transcription, a clinical documentation solution suite offered by M*Modal. The launch of this app represents the vendor’s response to a larger, growing demand within the healthcare community for capabilities supported by mobile devices, including smartphones.

1. M*Modal Fluency Flex Available as iTunes App
By Phyllis Carlin
January 2, 2014
On December 16, 2013, iTunes announced the availability of M*Modal Fluency Flex, V.2.0 for
authorized customers of M*Modal Fluency For Transcription, a clinical documentation solution
suite offered by M*Modal. The cloud-based
application was initially introduced
in Q4 2013 at the American Health
Information Management Association
(AHIMA) conference but was only
recently made available to customers.
The launch of this app represents the
vendor’s response to a larger, growing
demand within the healthcare community
for capabilities supported by mobile
devices, including smartphones.
As Dr. Michael Sanders, Medical
Director at St. Dominic-Jackson
Memorial Hospital in Jackson, Miss.
explained, “M*Modal Fluency Flex
Mobile lets our physicians work when and where they want to work. Physicians appreciate being
able to use their own smartphones, especially when a dictation device is hard to find or not
readily available. This flexible dictation platform provides mobility and freedom that our
physicians need and appreciate.”
Key V.2.0 features of the iPhone-compatible app include the following:
 Patient search by multiple criteria (name, patient ID, account number, barcode
sticker scanning)
 Patient lookup via demographics feed
 List of all work types supported
 Online and offline dictation capability
 Dictation upload via 3G or Wi-Fi connectivity
 Playback of draft and/or in progress dictation
 Job suspension for later review/resume/completion
 HIPAA guidelines security compliance (e.g., unique authentication, inactivity
timeout, device data encryption, secure communication over SSL, etc.,)
 Rapid turnaround transcription support
 Feedback communication to M*Modal support within the app

2. In addition to iPhone compatibility, the application is also designed to work on iPad and iPod
touch devices. It requires iOS 5.1 or later and is optimized for iPhone 5, which includes a
background noise eliminator. M*Modal Fluency Flex is a component of the integrated M*Modal
Fluency for Transcription product suite, which includes the following additional components:
 M*Modal Fluency for Transcription Editor
 M*Modal Fluency for Transcription Manage
 M*Modal Fluency for Transcription Dispatch
 M*Modal Fluency for Transcription Analytics
According to Duncan James, CEO of M*Modal, “M*Modal Developed this new mobile app
with the physician in mind, delivering accurate, high-quality medical transcription with the
convenience of anytime, anywhere dictation. The M*Modal Fluency Flex Mobile solution
promotes higher satisfaction, improved productivity and stronger adoption of HER systems by
employing technology that physicians want.”
Linking clinical decision support capabilities to M*Modal Fluency Flex is one major challenge
M*Modal faces in the process of making M*Modal Fluency Flex a more complete solution. This
would include things such as drug interaction and allergy alerts. At this time, M*Modal has not
announced a target date for this future enhancement.
MD Buyline members can find more information on M*Modal’s and competing applications in
the Voice Processing Technology Report.
About the Analyst: Phyllis Carlin, IT Analyst
As a specialist in IT software solutions at MD Buyline, Phyllis has primary responsibility for
several technologies, including bed management, continuous voice recognition, enterprise
resource planning (financial, supply chain and human capital management), financial decision
support, food and nutrition management, home healthcare, interactive patient communication,
real-time location systems, staff scheduling and time and attendance. Read Phyllis’ full
profile here.
Learn more about MD Buyline’s research at www.mdbuyline.com